BZETH Trademark

Trademark Overview


On Wednesday, September 10, 2025, a trademark application was filed for BZETH with the United States Patent and Trademark Office. The USPTO has given the BZETH trademark a serial number of 99385865. The federal status of this trademark filing is ACTION CONTINUING FINAL - MAILED as of Tuesday, July 14, 2026. This trademark is owned by BioZen Therapeutics Inc.. The BZETH trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of prescription and over-the-counter pharmaceutical preparations for humans for the treatment and management of enzyme-deficiency disorders, digestive insufficiency, chronic diseases addressed through biologic or biosimilar therapies, and rare diseases addressed through biologic or biosimilar therapies, including inflammatory diseases/disorders, autoimmune diseases/disorders, metabolic diseases/disorders, and endocrine diseases/disorders
bzeth

General Information


Serial Number99385865
Word MarkBZETH
Filing DateWednesday, September 10, 2025
Status649 - ACTION CONTINUING FINAL - MAILED
Status DateTuesday, July 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHouse mark for a full line of prescription and over-the-counter pharmaceutical preparations for humans for the treatment and management of enzyme-deficiency disorders, digestive insufficiency, chronic diseases addressed through biologic or biosimilar therapies, and rare diseases addressed through biologic or biosimilar therapies, including inflammatory diseases/disorders, autoimmune diseases/disorders, metabolic diseases/disorders, and endocrine diseases/disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 10, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioZen Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMonroe, NJ 08831
US

Trademark Events


Event DateEvent Description
Wednesday, September 10, 2025NEW APPLICATION ENTERED
Wednesday, September 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 10, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, December 10, 2025ASSIGNED TO EXAMINER
Monday, December 15, 2025NON-FINAL ACTION WRITTEN
Monday, December 15, 2025NON-FINAL ACTION E-MAILED
Monday, December 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 9, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 9, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 9, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 19, 2026FINAL REFUSAL WRITTEN
Thursday, March 19, 2026FINAL REFUSAL E-MAILED
Thursday, March 19, 2026NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, June 19, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, June 19, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 19, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 14, 2026ACTION CONTINUING A FINAL - COMPLETED
Tuesday, July 14, 2026CONTINUATION OF FINAL REFUSAL E-MAILED
Tuesday, July 14, 2026NOTIFICATION OF SUBSEQUENT FINAL EMAILED